A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...
Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...
VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
A Victorian hospital is about to begin world-first human trials of a potential breakthrough in treating high cholesterol.
Newspoint on MSN
Bad cholesterol: The hassle of medicines will end; only gene therapy will provide a one-time treatment for bad cholesterol
LDL Reduction: Studies have found that this therapy successfully reduced LDL cholesterol by up to 62 percent. Let's explain ...
An experimental one-time gene editing therapy significantly lowered LDL cholesterol in an early-stage trial, raising hopes ...
New cholesterol guidelines advise doctors to begin screening and treating people in their 30s, long before the risks of a heart attack and stroke become significantly higher. For the first time, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results